Monday, May 11, 2026 8:14:53 PM
So if anyone is concerned about health more so than their dividends, they would investigate under every rock and cranny. But first, let's see what some real FDA investigators found...but were silenced:::
https://conservativecolumn.com/2026/05/04/joe-biden-is-back-in-the-hot-seat-after-being-caught-in-a-shocking-cover-up/
Now knowing this, would one recommend to their family to go get in the jab line?
https://conservativecolumn.com/2026/05/04/joe-biden-is-back-in-the-hot-seat-after-being-caught-in-a-shocking-cover-up/
Now knowing this, would one recommend to their family to go get in the jab line?
Bearish
Recent PFE News
- European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors • Business Wire • 05/13/2026 10:45:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/12/2026 09:05:04 PM
- Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant) • GlobeNewswire Inc. • 05/12/2026 11:00:00 AM
- The Next Generation of the GLP-1 Revolution Is Already Underway • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- The Next Generation of the GLP-1 Revolution Is Already Underway • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/05/2026 08:42:09 PM
- Pfizer tops Q1 expectations on growth from newer products • IH Market News • 05/05/2026 03:05:10 PM
- Wall Street Set for Rebound as Oil Prices Retreat Sharply: Dow Jones, S&P, Nasdaq, Futures • IH Market News • 05/05/2026 01:19:45 PM
- Wall Street Poised for Gains as Oil Prices Retreat: Dow Jones, S&P, Nasdaq, Futures • UK Market News • 05/05/2026 01:19:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 11:03:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 11:01:20 AM
- Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance • Business Wire • 05/05/2026 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:20:12 PM
- Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma • Business Wire • 04/29/2026 10:45:00 AM
- Pfizer Reaches Three Settlement Agreements for VYNDAMAX • Business Wire • 04/28/2026 02:17:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:40:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:39:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:54 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 04/27/2026 10:23:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:22:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:22:30 PM
